Big Health, a maker of digital therapeutics, announced it was acquiring Limbix, creator of digital therapeutics for adolescents. The acquisition marks Big Health’s first entry into the adolescent ...

The Digital Therapeutics Alliance's annual conference kicked off Wednesday in Washington, D.C. The conference aims to bring together providers, payers, companies and regulatory agencies to discuss the ...

To be considered a true prescription digital therapeutic, the software must be authorized by the Food and Drug Administration ...

ARLINGTON, Va. & MILAN, Italy--(BUSINESS WIRE)--The Digital Therapeutics Alliance (DTA) and Healthware Group today announced a partnership to form a coalition convening thought leaders, policymakers, ...

The science behind digital therapeutics may sound dubious on paper—a smartphone app that can help someone quit smoking, reverse Type 2 diabetes or treat depression? In recent years, those promising ...

Dublin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The "Digital Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis" report has been added to ResearchAndMarkets.com's offering. The Digital ...

CMS is proposing expanding coverage of digital health devices used in some behavioral health treatment programs and asking for comments on adding even more devices. But will that be enough to spur ...

National Institute of Mental Health data shows that more than 17.3 million U.S. adults have suffered from an episode of major depression in the past year, and one in three are afflicted by an anxiety ...

CHICAGO — Digital therapeutics have the potential to give patients a new way to access care and lessen the burden on providers, said panelists at the 2023 HIMSS Global Health Conference & Exhibition ...

This is an excerpt from a story delivered exclusively to Business Insider Intelligence Digital Health Briefing subscribers. To receive the full story plus other insights each morning, click here.

Quality standards are necessary to help promote adoption of the novel class of interventions called digital therapeutics. This rapidly emerging industry needs to bring together regulators, engineers, ...

The conversations I had at this year’s J.P. Morgan Healthcare Conference were a microcosm of a dominant narrative coming out of one of the industry’s most influential weeks: How do we categorize ...